Formulary/Drug Comparison
211 - 225 of
357 Results
Sort Results:
Article:
Lemtrada (LEM-trah-dah, alemtuzumab) will be a new IV option for treating multiple sclerosis (MS)
June 2014
Article:
The new Abilify Maintena (aripiprazole) will put more focus on avoiding mix-ups with intramuscular "atypical" antipsychotics
May 2014